LOS ANGELES - Arizonar -- By CCHR International

Tens of thousands of American children who begin with a prescription for Attention Deficit Hyperactivity Disorder (ADHD) drugs ultimately end up on multiple powerful psychiatric drugs, sometimes even before they are old enough to attend elementary school. A new Wall Street Journal analysis of 2019–2023 Medicaid data found that children aged 3 to 14 who were started on an ADHD drug were more than five times as likely to be prescribed additional psychiatric drugs within four years compared to peers not on ADHD drugs. Most of the added drugs were antidepressants or antipsychotics—agents associated with severe, sometimes irreversible, side effects.[1] However, the mental health industry watchdog, Citizens Commission on Human Rights International (CCHR), conducted its own review of state-by-state Medicaid data through Freedom of Information Act (FOIA) requests, and the findings were even more alarming.

From the 32 states that provided records, nearly 3 million Medicaid-enrolled children ages 0–17 were prescribed psychiatric drugs in 2023, at a cost of $1.78 billion. Among them were 270,196 toddlers and preschool-aged children—an especially vulnerable population for whom many of these drugs are not FDA-approved. Because 18 states failed to provide data, the true national total is almost certainly far higher, likely surpassing 4 million children.

In the comprehensive breakdown of Medicaid child beneficiaries, more than 1.4 million were prescribed stimulants, 920,411 were given antidepressants, 605,746 received antianxiety drugs, 465,599 were put on antipsychotics, and 384,299 were prescribed mood stabilizers.

The Wall Street Journal reports that, according to 2021 federal data, 7.1 million American children aged 3 to 17 have been given an ADHD diagnosis. Roughly half are estimated to be on ADHD drugs. Data obtained by CCHR from IQVIA, a global healthcare analytics firm, revealed 3.15 million U.S. children (0–17) were prescribed ADHD stimulants in 2020, including 58,000 children under 5 years old.

More on The Arizonar

• Cyntexa Outlines a Principles-first Approach to Modern Enterprise Transformation
• Kickstarter And Creator Camp Partner To Support A New Era Of Creator-led Independent Film
• Top 66 People-Centric Leaders of 2025 Prove Taking Care of People Is Taking Care of Business
• Kliemann Brothers Announces 2025 Furnace Giveaway Winners
• Daniel Kaufman Launches a Vertically Integrated Real Estate and Investment Platform

The FDA approves these drugs only for children six and older, meaning young children are being prescribed potent stimulants "off-label" and without long-term safety research.

CCHR's Medicaid data collection three years later indicates the situation has not merely continued but likely worsened into a full-scale public-health failure demanding immediate federal intervention.

Jan Eastgate, president of CCHR International, says that these prescribing patterns reveal a federally funded "drug and polypharmacy pipeline"—one that urgently demands congressional and state oversight to protect children from what the watchdog calls "chemical assault and negligence disguised as care."

ADHD stimulant drugs carry a black box warning that they can cause addiction, even when taken exactly as prescribed.[2] A recent American Journal of Psychiatry study found that high doses of certain ADHD stimulants were associated with a more than five-fold increased risk of psychosis or mania.[3]

Danish physician and researcher Dr. Peter C. Gøtzsche warns that stimulants can also suppress normal childhood emotional and behavioral expression, causing apathy or indifference. In some studies, more than half of children developed depression or compulsive, and meaningless behaviors while taking them.[4]

Antidepressants also carry their own black box warning for suicidal thoughts and behavior in children and young adults.[5]

Antipsychotics are linked to metabolic damage, violent behavior, and neurological disorders.[6] One of their most severe effects is tardive dyskinesia (TD)—a disfiguring movement disorder caused by antipsychotics. Its symptoms resemble Parkinson's disease: involuntary movements of the lips, tongue, jaw, fingers, toes, or other body parts. TD can persist long after the drug is stopped—sometimes permanently. It is a reported risk in the pediatric population.[7]

Even worse, individuals developing TD are often prescribed more psychiatric drugs to counter the symptoms, exposing them to additional risks such as blurred vision, tremors, irregular heartbeat, drooling, restlessness, or akathisia—a well-documented driver of extreme agitation and suicidal or violent behavior.[8]

Eastgate says the expanding trend of drugging children with cocktails of psychotropics constitutes a national emergency: "This is a chemical assault on children, masking the real causes of their distress and too often worsening the very problems these drugs claim to treat. Federal and state intervention is urgently needed to abolish these negligent polypharmacy practices."

More on The Arizonar

• Long Long Tales: Bilingual Cartoon Series on Youtube Celebrating Chinese New Year
• MAX Illumination Redefines Cabinet Displays with New Edge-Lit LED Technology
• Impact Futures Group expands through acquisition of specialist healthcare sector training provider Caring for Care
• Veduis Launches VePrompts: Free AI Prompt Library And Toolbox With No Sign-Up Required
• The Taco Spot Celebrates Grand Opening in Surprise, AZ

Clinical experts agree the system is out of control. Alexandra Perez, a clinical psychologist at Emory University School of Medicine, told The Wall Street Journal she has seen children as young as four years old who were already on multiple psychiatric drugs. Many of these children had histories of trauma or adversity that were mislabeled as ADHD and drugged instead of addressed through non-drug support.

A 2021 review in Frontiers in Psychiatry summarized more than 20 years of research documenting substantial growth in pediatric psychotropic polypharmacy. In the studies reviewed:

• Up to 300,000 U.S. youth were found to be receiving three or more psychiatric drug classes simultaneously in certain Medicaid datasets.
• In one large Medicaid study of individuals aged 2–24 treated for ADHD: use of two or more ADHD drugs rose from 16.8% to 20.5%; prescriptions for two or more additional psychotropic classes increased from 26.0% to 40.7%
• Another study reported that 73.1% of children aged 6–18 receiving ADHD drugs had psychotropic polypharmacy, versus 26.9% in younger (2–5) and older (19–24) groups.[9]

Four years after those findings, the Wall Street Journal shows the trend has only worsened, as confirmed also by CCHR's own Medicaid analysis. Between 2019 and 2022:

• Nearly 5,000 providers prescribed ADHD drugs to at least 100 children each
• On average, 25% of these children also received one or more additional psychiatric drugs
• By 2023, 39,000 children (23%) on ADHD drugs were taking two or more psychiatric drugs simultaneously, and more than 4,400 were on four separate drugs at once.

CCHR, founded 56 years ago by the Church of Scientology and professor of psychiatry Thomas Szasz, said the latest data reveal an entrenched national failure to protect children. "Pumping kids with ADHD stimulants—often amphetamines—combined with mind-altering antidepressants, antipsychotics, or sedative-hypnotics, is evidence of a mental health system that has normalized harm under the guise of treatment," Eastgate said. "This is not care—it is harm. The practice should be abolished."

Sources:

[1] Shalini Ramachandran, et al., "Millions of Kids Are on ADHD Pills. For Many, It's the Start of a Drug Cascade," Wall Street Journal, 20 Nov. 2025, www.wsj.com/health/wellness/kids-adhd-drugs-medication-06dfa0b7?st=oRRSe8&reflink=desktopwebshare_permalink

[2] www.cchrint.org/2023/05/16/fda-finally-adds-addiction-to-black-box-warning-on-adhd-drugs/; www.fda.gov/media/168066/download

[3] www.cchrint.org/2024/09/20/new-study-warns-of-high-dose-adhd-drugs-inducing-psychosis/; www.nbcnews.com/health/mental-health/high-doses-adhd-drugs-linked-greater-risk-psychosis-rcna170707

[4] Peter C. Gøtzsche, MD, "Critical Psychiatry Textbook, Chapter 9: ADHD (Part Two)," Mad In America, 14 Aug. 2023

[5] medshun.com/article/why-do-antipsychotics-cause-violence

[6] pmc.ncbi.nlm.nih.gov/articles/PMC3004713/; medshun.com/article/why-do-antipsychotics-cause-violence; psychiatryonline.org/doi/10.1176/appi.ps.201500272

[7] pubmed.ncbi.nlm.nih.gov/38862692/

[8] www.cchrint.org/2021/10/11/consumers-beware-of-antipsychotics-long-term-debilitating-effects/

[9] pmc.ncbi.nlm.nih.gov/articles/PMC8236612/